Footnotes Source of support : Nil Conflict of interest : None REFERENCES 1.Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ
This study is an example of BPC-157's action in the presence of only one drug from the NSAID group, but its effect with other drugs from this group consistently shows the same beneficial and desired effect
A multicentre validation study of the diagnostic value of plasma neurofilament light
Disclosures: Carlos Alventosa-Mateu: Nothing to Disclose, Mara Dolores Ocete Mochn: Nothing to Disclose, Juan Catal Bauset: Nothing to Disclose, Javier Hernndez Felices: Nothing to Disclose, Juan Jos Urquijo Ponce: Nothing to Disclose, Mercedes Latorre Snchez: Nothing to Disclose, Inmaculada Castell Miralles: Nothing to Disclose, Concepcin Cardona Gimeno: Nothing to Disclose, Moiss Diago: Nothing to Disclose 564 ASSOCIATIONS BETWEEN BIOMARKERS AND MAGNETIC RESONANCE IMAGING-DERIVED ANALI SCORE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: ANALYSIS FROM THE PHASE 3 PRIMIS STUDY Michael Trauner 1 Jun Xu 2 Xiangyu Liu 3 Kaiyi Zhu 3 Xiaomin Lu 3 Sharlene Lim 3 William Barchuk 3 Lisa Boyette 3 Clare Tempany 4 Zachary Goodman 5 Atsushi Tanaka 6 Douglas Thorburn 7 Cynthia Levy 8 Christopher Bowlus 9 , 1 Medical University of Vienna, 2 Gilead Sciences, Inc., 3 Gilead Sciences Inc., 4 Brigham and Women's Hospital, Harvard University, 5 INOVA Fairfax Hospital, 6 Teikyo University School of Medicine, 7 Royal Free Hospital, 8 University of Miami, 9 University of California, Davis Background and Aim: Magnetic resonance cholangiopancreatography (MRCP) is the standard diagnostic method for patients with primary sclerosing cholangitis (PSC)
